BioCentury
ARTICLE | Company News

Newron, Loyola University Medical Center deal

October 19, 2009 7:00 AM UTC

Newron will return to Umberto Cornelli, a professor of pharmacology at the university, all rights to HF0420, an oligosaccharide in Phase I testing to prevent cancer-induced neuropathy. Newron made the...